03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Diabetes
Janet McGill: no photograph is held, so the academic plate is shown instead.
Academic
Janet McGill
Professor of Medicine in the Division of Endocrinology, Metabolism, and Lipid Research at Washington University School of Medicine in St. Louis, and Co-Chair of the study's Executive Committee
2
0
0
Sept 2026Oct 2026Nov 2026to date
2
press citations on 1 topic since 17 Sept 2026 · last quoted 17 Sept 2026
02 Quoted on · 1 of 29 topics
Janet McGill: key facts
- Kind of voice
- Academic
- Role
- Professor of Medicine in the Division of Endocrinology, Metabolism, and Lipid Research at Washington University School of Medicine in St. Louis, and Co-Chair of the study's Executive Committee
- Quoted on
- Diabetes
- Tracked press citations
- 2
- Most recently quoted
- 17 Sept 2026
04 The signal · where Janet McGill sits on diabetes
Ranked 24= of 100 voices quoted in the press on diabetes, level with 31 others on 2 citations.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1
Douglas TwenefourClinicianHead of Clinical, Diabetes UK15 - 2
Helen KnightRegulatorDirector of Medicines Evaluation, National Institute for Health and Care Excellence (NICE)11 - 3=
Parth NarendranAcademicProfessor of Diabetes Medicine; Honorary Consultant Physician (leads the Type 1 Diabetes clinical service at the Queen Elizabeth Hospital Birmingham), University of Birmingham8 - 24=Giedre CepukaityteSector leaderCognitive neuroscientist at tech company Thymia2
- 24=Kenneth CusterSector leaderPresident of Lilly's cardiometabolic health unit2
- 24=Janet McGillAcademicProfessor of Medicine in the Division of Endocrinology, Metabolism, and Lipid Research at Washington University School of Medicine in St. Louis, and Co-Chair of the study's Executive Committee2
- 24=Professor Dominic EhrmannAcademicProfessor at FIDAM (Research Institute Diabetes Academy Mergentheim), Bad Mergentheim, Germany2
- 24=Prof. Anette-Gabriele ZieglerAcademicchair of diabetes and gestational diabetes at the TUM University Hospital and director of the Helmholtz Munich Institute of Diabetes Research2
Showing the leaders and the ranks around 24=, of 100 voices · See every voice on the topic →
05 On the record · press
What Janet McGill has said
By outlet · linked articles
- bayer.com1
- fiercepharma.com1
Where Janet McGill has been quoted
- 01Bayer’s Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney diseasefiercepharma.com · 17 Sept 2026
- 02U.S. FDA approves finerenone for new indication in patients with chronic kidney disease associated with type 1 diabetesbayer.com · 17 Sept 2026
Verbatim
“provides an important new treatment option for a population that has continued to face substantial unmet need”
“For more than three decades, people with chronic kidney disease and type 1 diabetes have had limited options to address the risk of kidney disease progression. The approval of Kerendia to reduce UACR, which is expected to slow chronic kidney disease progression in adults with type 1 diabetes, provides an important new treatment option for a population that has continued to face substantial unmet need.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- First UK patient treated with NICE approved TeplizumabUniversity of Birmingham
- ICB refuses to fund GPs for transitioning patients from discontinued Levemir - Pulse Todaypulsetoday.co.uk
- Branding update for insulin pensDiabetes Research & Wellness Foundation
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.